Stock analysis searches answered, part 27 of 43

Jpc connectivity inc. bullish and bearish analyst opinions

What this search refers to. JPC Connectivity Inc. is a Taiwanese connector and cable manufacturer; Taiwan-traded issuers report on MOPS. Official source: mops.twse.com.tw.

No SEC filer could be matched to “Jpc connectivity inc. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Jpc connectivity inc.” appears in 1493+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “jpc” (search terms considered: jpc, connectivity).

In the 100 most relevant full-text hits returned for “Jpc connectivity inc.”, filings range from 2024-11-27 to 2026-10-23. The filers whose documents mention it most often are AMERICAN CENTURY ETF TRUST (CIK 0001710607) (52 hits); WisdomTree Trust (CIK 0001350487) (11 hits); SA FUNDS INVESTMENT TRUST (CIK 0001075065) (8 hits); FLEXSHARES TRUST (CIK 0001491978) (7 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 8 entities whose registered name contains the word “jpc”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “jpc” 8, “connectivity” 17. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “jpc” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Kalaris therapeutics inc bullish and bearish analyst opinions

For “Kalaris therapeutics inc bullish and bearish analyst opinions”, the matching SEC registrant is Kalaris Therapeutics, Inc., which trades as KLRS and files under Central Index Key 1754068. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Allovir, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-28, across 698 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-17 by Kalaris Therapeutics, Inc. (CIK 1754068) — source document:

We are a clinical stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases with major unmet medical needs. We are developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (“VEGF”) drug, specifically engineered to achieve extended intraocular retention with enhanced VEGF inhibition in patients with exudative and/or neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a “decoy receptor” (a VEGF trap), leveraging salient molecular properties of the human body’s native, highest affinity VEGF receptor 1. In head-to-head preclinical studies, TH103 showed more anti-VEGF activity and longer duration of activity compared to aflibercept, the current market-leading anti-VEGF agent, which also functions as a decoy receptor VEGF trap but differs from TH103 in key molecular elements.

Financial trend for Kalaris Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$168.71 million (2022-12-31) to -$43.44 million (2025-12-31), a change of +74.3%; total assets went from $277.08 million (2022-12-31) to $121.74 million (2025-12-31), a change of -56.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1754068, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Kalaris Therapeutics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Kalaris Therapeutics, Inc. (CIK 1754068) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-17. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 71 8-K or 6-K reports in Kalaris Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-06 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1754068 is on the EDGAR company page; the latest 10-K there is dated 2026-03-17 and the oldest filing in the recent index dates from 2018-10-02. Insider trades for Kalaris Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kdk stock reddit

For “Kdk stock reddit”, the matching SEC registrant is Kodiak AI, Inc., which trades as KDK, KDKRW and files under Central Index Key 1853138. EDGAR puts it in the “Services-Computer Integrated Systems Design” industry code with DE as its state or country of incorporation; its earlier registered name was Kodiak Al, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 144 filed 2026-09-30, across 259 filings on record. This is reference material, not trading advice.

Financial trend for Kodiak AI, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $16.95 million (2023-12-31) to $3.80 million (2025-12-31), a change of -77.6%; net income (loss) went from -$3,542 (2022-12-31) to -$585.52 million (2025-12-31), a change of -16530814.7%; total assets went from $512,595 (2022-12-31) to $159.41 million (2025-12-31), a change of +30998.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1853138, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Kodiak AI, Inc. did not tag for that period.

Reddit threads about Kodiak AI, Inc., CIK 1853138, are user opinions, not disclosures. Claims made there can be checked against the filer record: 259 filings sit in its recent EDGAR index, the newest a 144 dated 2026-09-30, and 28 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 26 8-K or 6-K reports in Kodiak AI, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 259 recent EDGAR filings, Kodiak AI, Inc. most often filed 425 (39), 4 (28), 8-K (26), 3 (21). A selection from 2026-08-14 to 2026-09-30:

The full record for CIK 1853138 is on the EDGAR company page; the latest 10-K there is dated 2026-03-11 and the oldest filing in the recent index dates from 2021-05-14. Insider trades for Kodiak AI, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Korsana biosciences, inc. bullish and bearish analyst opinions

For “Korsana biosciences, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Korsana Biosciences, Inc., which trades as KRSA and files under Central Index Key 1755237. EDGAR puts it in the “Pharmaceutical Preparations” industry code with MA as its state or country of incorporation; its earlier registered name was Cyclerion Therapeutics, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 144 filed 2026-10-22, across 389 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by Korsana Biosciences, Inc. (CIK 1755237) — source document:

Our current strategic focus is centered on the development of a novel therapeutic approach for neuropsychiatric conditions, with the lead indication being treatment-resistant depression (“TRD”), which we believe represents a substantial clinical and commercial opportunity. Primary Focus on New Potential Treatment for Treatment Resistant Depression (“TRD” ) Over the past year, we have refined our strategic direction toward programs that combine established pharmacologic agents with enabling technologies designed to improve precision, reproducibility, and patient outcomes. As part of this strategy, Cyclerion has evaluated multiple opportunities and prioritized CYC-126, an individualized therapy for TRD as our foundational development program. • In September 2025, we entered into a license agreement with the Massachusetts Institute of Technology (“MIT”) for intellectual property supporting this program (the “MIT License Agreement”).

Financial trend for Korsana Biosciences, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $297,000 (2022-12-31) to $2.07 million (2025-12-31), a change of +598.3%; net income (loss) went from -$44.08 million (2022-12-31) to -$3.53 million (2025-12-31), a change of +92.0%; total assets went from $18.08 million (2022-12-31) to $9.98 million (2025-12-31), a change of -44.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1755237, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Korsana Biosciences, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Korsana Biosciences, Inc. (CIK 1755237) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-09-11, and the most recent 10-K annual report was filed 2026-03-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 69 8-K or 6-K reports in Korsana Biosciences, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-01 to 2026-09-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1755237 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2018-10-09. Insider trades for Korsana Biosciences, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kvh industries, inc. bullish and bearish analyst opinions

For “Kvh industries, inc. bullish and bearish analyst opinions”, the matching SEC registrant is KVH INDUSTRIES INC \DE\, which trades as KVHI and files under Central Index Key 1007587. EDGAR puts it in the “Communications Services, NEC” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-13, across 1002 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-10 by KVH INDUSTRIES INC \DE\ (CIK 1007587) — source document:

These statements are inherently uncertain, and actual events could differ materially from our predictions. Important factors that could cause actual events to vary from our predictions include those discussed in this annual report under the headings “Item 7. We urge readers to review carefully the risk factors described in this annual report and in the other documents that we file with the Securities and Exchange Commission. Additional Information Available Our principal Internet address is www.kvh.com . Our website provides a hyperlink to a third-party website through which our annual, quarterly, and current reports, as well as amendments to those reports, are available free of charge. We believe these reports are made available as soon as reasonably practicable after we electronically file them with, or furnish them to, the SEC. We do not provide any information regarding our SEC filings directly to the third-party website, and we do not check its accuracy or completeness.

Financial trend for KVH INDUSTRIES INC \DE\ from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $24.03 million (2022-12-31) to -$7.38 million (2025-12-31), a change of -130.7%; total assets went from $196.25 million (2022-12-31) to $151.50 million (2025-12-31), a change of -22.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1007587, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures KVH INDUSTRIES INC \DE\ did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on KVH INDUSTRIES INC \DE\ (CIK 1007587) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-03-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 100 8-K or 6-K reports in KVH INDUSTRIES INC \DE\’s recent EDGAR index, the 4 listed here run from 2026-03-10 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1007587 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2013-08-06. Insider trades for KVH INDUSTRIES INC \DE\ appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lakeshore acquisition iii corp. bullish and bearish analyst opinions

For “Lakeshore acquisition iii corp. bullish and bearish analyst opinions”, the matching SEC registrant is Lakeshore Acquisition III Corp., which trades as LCCC, LCCCR, LCCCU and files under Central Index Key 2049248. EDGAR puts it in the “Blank Checks” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G filed 2026-10-07, across 56 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-04 by Lakeshore Acquisition III Corp. (CIK 2049248) — source document:

Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”) and one right that entitles the holder thereof to receive one-sixth (1/6) of one Ordinary Share upon consummation of the Company’s initial business combination (“Right”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $69,000,000. Simultaneously with the closing of the IPO, the Company consummated a private placement (the “Private Placement”) in which RedOne Investment Limited (the “Sponsor”) purchased 280,000 private units (the “Private Placement Units”) at a price of $10.00 per Private Unit, generating total gross proceeds of $2,800,000. The Private Placement Units are identical to the Units sold in the IPO except that the Private Placement Units are subject to certain transfer restrictions.

Financial trend for Lakeshore Acquisition III Corp. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $1.26 million; total assets went from $310,876 (2024-12-31) to $71.62 million (2025-12-31), a change of +22939.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2049248, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Lakeshore Acquisition III Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Lakeshore Acquisition III Corp. (CIK 2049248) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-02-04. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Lakeshore Acquisition III Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-04-30.

Current reports. Of the 8 8-K or 6-K reports in Lakeshore Acquisition III Corp.’s recent EDGAR index, the 4 listed here run from 2026-07-30 to 2026-09-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2049248 is on the EDGAR company page; the latest 10-K there is dated 2026-02-04 and the oldest filing in the recent index dates from 2025-01-15. Insider trades for Lakeshore Acquisition III Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lh hotel leasehold real estate investment trust bullish and bearish analyst opinions

What this search refers to. LH Hotel Leasehold Real Estate Investment Trust is a Thai REIT holding hotel leaseholds, listed on the Stock Exchange of Thailand; its disclosures are on SET. Official source: www.set.or.th.

No SEC filer could be matched to “Lh hotel leasehold real estate investment trust bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Lh hotel leasehold real estate investment” appears in 100+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “hotel” (search terms considered: hotel, leasehold, real, estate, investment, trust).

A broader EDGAR full-text search for the shorter phrase “Lh hotel leasehold” finds 108+ filing documents; among the top 100, the filers mentioning it most are SPDR INDEX SHARES FUNDS (CIK 0001168164) (54); DBX ETF TRUST (CIK 0001503123) (34); VANGUARD INTERNATIONAL EQUITY INDEX FUNDS (CIK 0000857489) (6). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Lh hotel leasehold real estate investment”, filings range from 2019-04-25 to 2026-08-28. The filers whose documents mention it most often are SPDR INDEX SHARES FUNDS (CIK 0001168164) (57 hits); DBX ETF TRUST (CIK 0001503123) (37 hits); DBX ETF Trust (CIK 0001503123) (4 hits); Fidelity Rutland Square Trust II (CIK 0001364924) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 197+ entities whose registered name contains the word “hotel”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “hotel” 492, “leasehold” 12, “real” 477, “estate” 475, “investment” 484, “trust” 488. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “hotel” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Lianhe chemical technology co., ltd. bullish and bearish analyst opinions

Read from its name, “Lianhe chemical technology co., ltd.” is a China, Taiwan, Korea or Japan entity — “Co., Ltd.” is the English rendering used by limited companies across East Asia. Its accounts and exchange notices are published through the home-exchange disclosure system (SSE/SZSE in mainland China, MOPS in Taiwan, DART in Korea, EDINET in Japan) (mops.twse.com.tw); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Lianhe chemical technology co., ltd. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Lianhe chemical technology co., ltd.” appears in 2969+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “lianhe” (search terms considered: lianhe, chemical, technology).

A broader EDGAR full-text search for the shorter phrase “Lianhe chemical technology” finds 3010+ filing documents; among the top 100, the filers mentioning it most are DBX ETF TRUST (CIK 0001503123) (25); Franklin Templeton ETF Trust (CIK 0001655589) (19); BLACKROCK FUNDS (CIK 0000844779) (14). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Lianhe chemical technology co., ltd.”, filings range from 2014-11-25 to 2026-08-27. The filers whose documents mention it most often are DBX ETF TRUST (CIK 0001503123) (25 hits); Franklin Templeton ETF Trust (CIK 0001655589) (22 hits); BLACKROCK FUNDS (CIK 0000844779) (14 hits); SA FUNDS INVESTMENT TRUST (CIK 0001075065) (10 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 1 entities whose registered name contains the word “lianhe”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “lianhe” 1, “chemical” 227, “technology” 485. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “lianhe” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Linkhome holdings inc. bullish and bearish analyst opinions

For “Linkhome holdings inc. bullish and bearish analyst opinions”, the matching SEC registrant is Linkhome Holdings Inc., which trades as LHAI and files under Central Index Key 2017758. EDGAR puts it in the “Real Estate Agents & Managers (For Others)” industry code with NV as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4/A filed 2026-10-23, across 82 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-26 by Linkhome Holdings Inc. (CIK 2017758) — source document:

Linkhome is an artificial intelligence-driven property technology company. By using HomeGPT, a Linkhome-developed real estate artificial intelligence model, combined with financial innovation and in conjunction with our dedicated team of agents, we have made significant and cost-effective improvements to the business model of buying and selling homes. Through our subsidiaries, we operate an artificial intelligence real estate platform with the goal of providing customers with end-to-end real estate solutions and services, initially comprising real estate brokerage services, Cash Offer, and mortgage service. Our mission is to redefine the real estate experience to be efficient and affordable for all consumers through artificial intelligence. Our vision is to help everyone own their home and achieve the dream of homeownership.

Financial trend for Linkhome Holdings Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $1.37 million (2023-12-31) to $20.99 million (2025-12-31), a change of +1432.6%; net income (loss) went from $151,193 (2023-12-31) to $74,874 (2025-12-31), a change of -50.5%; total assets went from $839,945 (2023-12-31) to $10.02 million (2025-12-31), a change of +1092.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2017758, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Linkhome Holdings Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Linkhome Holdings Inc. (CIK 2017758) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 9 8-K or 6-K reports in Linkhome Holdings Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-17 to 2026-10-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2017758 is on the EDGAR company page; the latest 10-K/A there is dated 2026-05-19 and the oldest filing in the recent index dates from 2024-04-11. Insider trades for Linkhome Holdings Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lisata therapeutics, inc. bullish and bearish analyst opinions

For “Lisata therapeutics, inc. bullish and bearish analyst opinions”, the matching SEC registrant is LISATA THERAPEUTICS, INC., which trades as LSTA and files under Central Index Key 320017. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Caladrius Biosciences, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a ARS filed 2026-10-19, across 1001 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-12 by LISATA THERAPEUTICS, INC. (CIK 320017) — source document:

Lisata Therapeutics, Inc. (together with its subsidiaries, the “Company”) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other serious diseases. Our investigational product, certepetide (formerly known as LSTA1 or CEND-1), is designed to activate a novel uptake pathway (the C-end rule active transport mechanism) that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. Certepetide actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are expected to remain unaffected. Certepetide has also been shown to modify the tumor microenvironment (“TME”) by reducing T-regulatory cells and augmenting cytotoxic T cells, thereby making tumors more susceptible to immunotherapies while also inhibiting the metastatic cascade (i.e., the spread of cancer to other parts of the body).

Financial trend for LISATA THERAPEUTICS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$54.23 million (2022-12-31) to -$16.59 million (2025-12-31), a change of +69.4%; total assets went from $73.03 million (2022-12-31) to $17.74 million (2025-12-31), a change of -75.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 320017, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures LISATA THERAPEUTICS, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on LISATA THERAPEUTICS, INC. (CIK 320017) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2025-11-06, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 211 8-K or 6-K reports in LISATA THERAPEUTICS, INC.’s recent EDGAR index, the 4 listed here run from 2026-07-24 to 2026-10-14, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 320017 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-28 and the oldest filing in the recent index dates from 2011-05-17. Insider trades for LISATA THERAPEUTICS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Locafy ltd bullish and bearish analyst opinions

For “Locafy ltd bullish and bearish analyst opinions”, the matching SEC registrant is Locafy Ltd, which trades as LCFY, LCFYW and files under Central Index Key 1875547. EDGAR puts it in the “Services-Computer Programming, Data Processing, Etc.” industry code with Australia as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-06 (this view begins at filings dated on or before 2026-03-18), across 113 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2025-11-12 by Locafy Ltd (CIK 1875547) (passage 2, continuing from the earlier excerpt) — source document:

The SEC maintains an internet site at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. As a foreign private issuer, we are exempt from the rules under the Exchange Act that prescribe the furnishing and content of proxy statements to shareholders. B. Business Overview Overview We are an Australian company currently focused on commercializing our Software as a Service (“SaaS”) online marketing technology (“Technology”), which primarily delivers a cost-effective location-based digital marketing solution for small businesses in our key target markets of USA, Australia and Canada. Our Technology stack and product solution incorporates three key elements: ● Business Listing syndication to generate wider online search prominence; ● Landing Pages optimized for both traditional search and AI search; and ● Map Boosting technology that increases visibility in Google’s Local Pack search results.

Financial trend for Locafy Ltd from annual reports, periods 2020-06-30 to 2021-06-30: net income (loss) went from -2,321,827 AUD (2020-06-30) to -995,766 AUD (2021-06-30), a change of +57.1%; total assets was tagged only for 2021-06-30 at 2,781,580 AUD. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1875547, tags Assets, ProfitLoss; 2 periods shown, dashes mark figures Locafy Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Locafy Ltd (CIK 1875547) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2025-11-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 59 8-K or 6-K reports in Locafy Ltd’s recent EDGAR index, the 4 listed here run from 2025-08-29 to 2025-11-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1875547 is on the EDGAR company page; the latest 20-F there is dated 2025-11-12 and the oldest filing in the recent index dates from 2021-09-27. One example from this record is the F-3 filed 2026-08-04 (document). Insider trades for Locafy Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lpcn stock news

For “Lpcn stock news”, the matching SEC registrant is Lipocine Inc., which trades as LPCN and files under Central Index Key 1535955. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was MARATHON BAR CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20, across 821 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-10 by Lipocine Inc. (CIK 1535955) — source document:

Lipocine Inc. (“Lipocine” or the “Company”) is incorporated under the laws of the State of Delaware. We are a biopharmaceutical company focused on leveraging our proprietary technology platform to develop innovative products with effective oral delivery of previously difficult to deliver molecules. Our proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. Our primary development programs are based on oral delivery solutions for poorly bioavailable drugs. We have a portfolio of differentiated innovative product candidates that target high unmet needs for neurological and psychiatric CNS disorders, liver disease, and hormone supplementation for men and women. On January 12, 2024, we entered into a license agreement (the “Verity License Agreement”) with Gordon Silver Limited (“GSL”) and Verity Pharmaceuticals, Inc. (“Verity” or our “Licensee”), pursuant to which we granted to Verity an exclusive, royalty-bearing, sublicensable right and license to commercialize TLANDO for TRT in the U.S. and Canada (the “Licensed Verity Territory”).

Financial trend for Lipocine Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $500,000 (2022-12-31) to $1.98 million (2025-12-31), a change of +295.3%; net income (loss) went from -$10.76 million (2022-12-31) to -$9.63 million (2025-12-31), a change of +10.5%; total assets went from $37.54 million (2022-12-31) to $17.01 million (2025-12-31), a change of -54.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1535955, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Lipocine Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Lipocine Inc. (CIK 1535955) filed 422 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-20, and its overall latest filing is a 8-K dated 2026-10-20. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 422 8-K or 6-K reports in Lipocine Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-14 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1535955 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2011-11-30. Insider trades for Lipocine Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Luda technology group limited bullish and bearish analyst opinions

For “Luda technology group limited bullish and bearish analyst opinions”, the matching SEC registrant is Luda Technology Group Ltd, which trades as LUD and files under Central Index Key 1984124. EDGAR puts it in the “Steel Pipe & Tubes” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-21, across 82 filings on record. This is reference material, not trading advice.

The diagram below illustrates our corporate structure as of the date of this annual report: For details of our principal shareholders’ ownership, please refer to the beneficial ownership table in “Item 6. Directors, Senior Management and Employees—E. Share Ownership”. The background and ownership of our subsidiaries as of the date of this annual report are as follows: Name Background Ownership Luda BVI Incorporated on October 25, 2021 under the laws of the BVI as an investment holding company and owned by Diamond Horses Group Limited prior to the reorganization. As part of the reorganization, Luda Cayman has entered into a sale and purchase agreement to acquire Luda BVI on August 14, 2023.

Analyst ratings, price targets and “bullish” or “bearish” calls on Luda Technology Group Ltd (CIK 1984124) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-05-15. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Updated Oct 25, 2026 ET

Magna terra minerals inc. bullish and bearish analyst opinions

For “Magna terra minerals inc. bullish and bearish analyst opinions”, the matching SEC registrant is Magna Terra Minerals Inc., which trades as none listed and files under Central Index Key 1827161. EDGAR puts it in the “no SIC description” industry code with Quebec, Canada as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a D filed 2020-10-09, across 1 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Magna Terra Minerals Inc. (CIK 1827161) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

What kind of filer this is matters for “Magna terra minerals inc. bullish and bearish analyst opinions”: Magna Terra Minerals Inc.’s EDGAR record from 2020-10-09 to 2020-10-09 consists only of Form D notices of exempt private offerings, which means it raised money privately rather than registering shares for public trading. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it; as a company organised in Quebec, Canada, its own reports would be with the Canadian Securities Administrators’ SEDAR+ system (www.sedarplus.ca).

Other filings. Across its 1 recent EDGAR filings, Magna Terra Minerals Inc. most often filed D (1). A selection from 2020-10-09 to 2020-10-09:

The full record for CIK 1827161 is on the EDGAR company page and the oldest filing in the recent index dates from 2020-10-09. Insider trades for Magna Terra Minerals Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mbody ai ltd. bullish and bearish analyst opinions

For “Mbody ai ltd. bullish and bearish analyst opinions”, the matching SEC registrant is MBody AI Ltd., which trades as MBAI and files under Central Index Key 1610590. EDGAR puts it in the “Services-Computer Integrated Systems Design” industry code with Israel as its state or country of incorporation; its earlier registered name was Check-Cap Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a EFFECT filed 2026-09-28, across 450 filings on record. This is reference material, not trading advice.

Financial trend for MBody AI Ltd. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$19.11 million (2022-12-31) to $4.14 million (2025-12-31), a change of +121.7%; total assets went from $45.44 million (2022-12-31) to $7.49 million (2025-12-31), a change of -83.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1610590, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures MBody AI Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on MBody AI Ltd. (CIK 1610590) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 225 8-K or 6-K reports in MBody AI Ltd.’s recent EDGAR index, the 4 listed here run from 2026-08-26 to 2026-09-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 450 recent EDGAR filings, MBody AI Ltd. most often filed 6-K (225), EFFECT (18), 425 (15), F-1/A (14). A selection from 2026-09-18 to 2026-09-28:

The full record for CIK 1610590 is on the EDGAR company page; the latest 20-F there is dated 2026-04-27 and the oldest filing in the recent index dates from 2014-02-18. Insider trades for MBody AI Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mcgrath rentcorp bullish and bearish analyst opinions

For “Mcgrath rentcorp bullish and bearish analyst opinions”, the matching SEC registrant is MCGRATH RENTCORP, which trades as MGRC and files under Central Index Key 752714. EDGAR puts it in the “Services-Equipment Rental & Leasing, NEC” industry code with CA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-02, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-25 by MCGRATH RENTCORP (CIK 752714) — source document:

McGrath RentCorp (the “Company”) is a California corporation organized in 1979 with corporate offices located in Livermore, California. The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol “MGRC”. References in this report to the “Company”, “we”, “us”, and “ours” refer to McGrath RentCorp and its subsidiaries, unless the context requires otherwise. The Company is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers and electronic test equipment. Although the Company’s primary emphasis is on equipment rentals, sales of equipment occur in the normal course of business. At December 31, 2025, the Company was comprised of four reportable business segments: (1) its modular building segment (“Mobile Modular”); (2) its portable storage container segment (“Portable Storage”); (3) its electronic test equipment segment (“TRS-RenTelco”); and (4) its classroom manufacturing business selling modular buildings used primarily as classrooms in California (“Enviroplex”).

Financial trend for MCGRATH RENTCORP from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $635.66 million (2022-12-31) to $944.24 million (2025-12-31), a change of +48.5%; net income (loss) went from $115.14 million (2022-12-31) to $156.31 million (2025-12-31), a change of +35.8%; total assets went from $1.71 billion (2022-12-31) to $2.36 billion (2025-12-31), a change of +38.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 752714, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures MCGRATH RENTCORP did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on MCGRATH RENTCORP (CIK 752714) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-02-25. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 98 8-K or 6-K reports in MCGRATH RENTCORP’s recent EDGAR index, the 4 listed here run from 2026-04-29 to 2026-07-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 752714 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2014-05-15. Insider trades for MCGRATH RENTCORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mediaco holding inc. bullish and bearish analyst opinions

For “Mediaco holding inc. bullish and bearish analyst opinions”, the matching SEC registrant is Mediaco Holding Inc., which trades as MDIA and files under Central Index Key 1784254. EDGAR puts it in the “Radio Broadcasting Stations” industry code with IN as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a S-8 filed 2026-10-07, across 344 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Mediaco Holding Inc. (CIK 1784254) — source document:

MediaCo Holding Inc. (“MediaCo” or the “Company”) is an owned and operated multi-media company formed in Indiana in 2019, focused on radio, television, digital advertising, premium programming and events. On April 17, 2024, MediaCo Holding Inc. and its wholly-owned subsidiary MediaCo Operations LLC, a Delaware limited liability company (“Purchaser”), entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Estrella Broadcasting, Inc., a Delaware corporation (“Estrella”), and SLF LBI Aggregator, LLC, a Delaware limited liability company (“Aggregator”) and affiliate of HPS Investment Partners, LLC (“HPS”), pursuant to which Purchaser purchased substantially all of the assets of Estrella and its subsidiaries (other than certain broadcast assets owned by Estrella and its subsidiaries (the “Estrella Broadcast Assets”)) (the “Purchased Assets”), and assumed substantially all of the liabilities (the “Assumed Liabilities”) of Estrella and its subsidiaries (such transactions, collectively, the “Estrella Acquisition”).

Financial trend for Mediaco Holding Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $38.59 million (2022-12-31) to $133.34 million (2025-12-31), a change of +245.5%; net income (loss) went from $30.91 million (2022-12-31) to -$1.30 million (2024-12-31), a change of -104.2%; total assets went from $96.70 million (2022-12-31) to $291.06 million (2025-12-31), a change of +201.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1784254, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Mediaco Holding Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Mediaco Holding Inc. (CIK 1784254) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-14, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 55 8-K or 6-K reports in Mediaco Holding Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-21 to 2026-10-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1784254 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2019-08-13. Insider trades for Mediaco Holding Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mei ah entertainment group limited bullish and bearish analyst opinions

“Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. The name “Mei ah entertainment group limited” therefore points to a company organised in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), and its official disclosures are on that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk), not on EDGAR.

No SEC filer could be matched to “Mei ah entertainment group limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Mei ah entertainment group limited” appears in 6 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “mei” (search terms considered: mei, entertainment).

A broader EDGAR full-text search for the shorter phrase “Mei ah entertainment” finds 498+ filing documents; among the top 100, the filers mentioning it most are SA FUNDS INVESTMENT TRUST (CIK 0001075065) (46); WPP plc (WPP, WPPGF) (CIK 0000806968) (12); VANGUARD INTERNATIONAL EQUITY INDEX FUNDS (CIK 0000857489) (12). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 6 most relevant full-text hits returned for “Mei ah entertainment group limited”, filings range from 2005-09-09 to 2017-08-30. The filers whose documents mention it most often are PCCW LTD (CIK 0000842519) (3 hits); COLLEGE RETIREMENT EQUITIES FUND (CIK 0000777535) (2 hits); SCHWAB STRATEGIC TRUST (CIK 0001454889) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 80 entities whose registered name contains the word “mei”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “mei” 80, “entertainment” 482. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “mei” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Mgic investment corporation mtg mobile apps

For “Mgic investment corporation mtg mobile apps”, the matching SEC registrant is MGIC INVESTMENT CORP, which trades as MTG and files under Central Index Key 876437. EDGAR puts it in the “Surety Insurance” industry code with WI as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-02, across 1004 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-25 by MGIC INVESTMENT CORP (CIK 876437) — source document:

See the "Glossary of terms and acronyms" for definitions and descriptions of terms used throughout this annual report. A. General We are a holding company and through wholly-owned subsidiaries we provide private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. In 2025, our total revenues were $1.2 billion and our primary NIW was $60.2 billion. As of December 31, 2025, our direct primary IIF was $303.1 billion and our direct primary RIF was $81.2 billion. For further information about our results of operations, see our consolidated financial statements in Item 8 and our MD&A in Item 7 . As of December 31, 2025, our principal mortgage insurance subsidiary, MGIC, was licensed in all 50 states of the United States, the District of Columbia, Puerto Rico and Guam.

Financial trend for MGIC INVESTMENT CORP from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.17 billion (2022-12-31) to $1.21 billion (2025-12-31), a change of +3.5%; net income (loss) went from $865.35 million (2022-12-31) to $738.35 million (2025-12-31), a change of -14.7%; total assets went from $6.21 billion (2022-12-31) to $6.64 billion (2025-12-31), a change of +6.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 876437, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures MGIC INVESTMENT CORP did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for MGIC INVESTMENT CORP (CIK 876437) lists its business address as 250 EAST KILBOURN AVENUE, MILWAUKEE, WI, which helps confirm you are on the right company’s site.

Current reports. Of the 74 8-K or 6-K reports in MGIC INVESTMENT CORP’s recent EDGAR index, the 4 listed here run from 2026-02-02 to 2026-07-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 876437 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2018-03-05. Insider trades for MGIC INVESTMENT CORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Micropolis ai robotics press release october 2026

For “Micropolis ai robotics press release october 2026”, the matching SEC registrant is Micropolis AI Robotics, which trades as MCRP and files under Central Index Key 1993431. EDGAR puts it in the “Motor Vehicle Parts & Accessories” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Micropolis Holding Co. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-23 (this view begins at filings dated on or before 2026-04-06), across 71 filings on record. This is reference material, not trading advice.

Updated Oct 25, 2026 ET

Micropolis robotics earnings sec filing latest

For “Micropolis robotics earnings sec filing latest”, the matching SEC registrant is Micropolis AI Robotics, which trades as MCRP and files under Central Index Key 1993431. EDGAR puts it in the “Motor Vehicle Parts & Accessories” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Micropolis Holding Co. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-23 (this view begins at filings dated on or before 2025-01-29), across 71 filings on record. This is reference material, not trading advice.

More of the filing record for Micropolis AI Robotics (CIK 1993431), filings 2025-01-15 to 2025-03-04: CORRESP on 2025-03-04; CORRESP on 2025-03-04; F-1/A on 2025-02-07; FWP on 2025-01-29; CORRESP on 2025-01-15. Each form type has a fixed purpose under SEC rules, so the mix shows what kind of events the company has been reporting.

Micropolis reports in UAE dirhams (AED), not U.S. dollars, so revenue of 130,043 AED for 2024 is a small figure once converted at the dirham’s fixed peg of about 3.67 to the dollar. For the latest earnings, look for the most recent 6-K on the EDGAR company page and its press-release exhibit; the F-1/A and CORRESP entries listed here belong to the 2024–2025 registration process for its U.S. listing, when SEC staff comments were answered in correspondence before the offering became effective.

Mingteng international corporation inc. bullish and bearish analyst opinions

For “Mingteng international corporation inc. bullish and bearish analyst opinions”, the matching SEC registrant is Mingteng International Corp Inc., which trades as MTEN and files under Central Index Key 1948099. EDGAR puts it in the “Metal Doors, Sash, Frames, Moldings & Trim” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-06, across 101 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Mingteng International Corp Inc. (CIK 1948099) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Updated Oct 25, 2026 ET

Nakamoto packs co.,ltd. bullish and bearish analyst opinions

For “Nakamoto packs co.,ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Nakamoto Inc., which trades as NAKA, NAKAW and files under Central Index Key 1946573. EDGAR puts it in the “Finance Services” industry code with DE as its state or country of incorporation; its earlier registered name was Kindly MD, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4/A filed 2026-10-15, across 252 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by Nakamoto Inc. (CIK 1946573) — source document:

Nakamoto Inc., a Delaware corporation, is a Bitcoin company building a global portfolio of Bitcoin-native companies. We hold Bitcoin on our balance sheet and, through our ecosystem-wide presence, seek to provide investors with exposure to Bitcoin’s global growth and to leverage our treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, advisory and more. We were formed in 2019 as a patient-first healthcare company redefining value-based care and patient-centered medical services. On August 14, 2025, we acquired a privately held Bitcoin treasury company through a reverse merger and began our transformation into a Bitcoin operating company. On February 20, 2026, we acquired BTC Inc (“BTC Inc”), the leading provider of Bitcoin-related media and events, and UTXO Management GP, LLC (“UTXO”), an investment firm focused on private and public Bitcoin companies, pursuant to separate merger transactions (the “BTC Merger” and “UTXO Merger,” respectively, and, collectively, the “Mergers”).

Financial trend for Nakamoto Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $3.77 million (2023-12-31) to $1.82 million (2025-12-31), a change of -51.7%; net income (loss) went from -$1.62 million (2023-12-31) to -$52.23 million (2025-12-31), a change of -3129.1%; total assets went from $1.10 million (2023-12-31) to $730.61 million (2025-12-31), a change of +66367.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1946573, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Nakamoto Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Nakamoto Inc. (CIK 1946573) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-14, and the most recent 10-K annual report was filed 2026-03-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 45 8-K or 6-K reports in Nakamoto Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-22 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1946573 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2022-09-15. Insider trades for Nakamoto Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nanoviricides, inc. bullish and bearish analyst opinions

For “Nanoviricides, inc. bullish and bearish analyst opinions”, the matching SEC registrant is NANOVIRICIDES, INC., which trades as NNVC and files under Central Index Key 1379006. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 424B5 filed 2026-10-21, across 556 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-09-28 by NANOVIRICIDES, INC. (CIK 1379006) — source document:

Organization and Nature of Business NanoViricides, Inc. (the “Company”, “NanoViricides”, “we,” or “us”) was incorporated in Nevada on April 1, 2005, and redomiciled to Delaware effective May 30, 2023. Our corporate offices are located at 1 Controls Drive, Shelton, Connecticut 06484 and our telephone number is (203) 937-6137. Our Website is located at http://www.Nanoviricides.com . We do not incorporate by reference into this Annual Report the information on or accessible through our website, and you should not consider it part of this Annual Report. On September 25, 2013, the Company’s common stock began trading on the New York Stock Exchange American under the symbol, “NNVC”. We are a clinical stage company.

Financial trend for NANOVIRICIDES, INC. from annual reports, periods 2023-06-30 to 2026-06-30: revenue went from $0 (2023-06-30) to $0 (2026-06-30); net income (loss) went from -$8.59 million (2023-06-30) to -$8.22 million (2026-06-30), a change of +4.3%; total assets went from $16.90 million (2023-06-30) to $9.87 million (2026-06-30), a change of -41.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1379006, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerIncludingAssessedTax; 4 periods shown, dashes mark figures NANOVIRICIDES, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on NANOVIRICIDES, INC. (CIK 1379006) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-09-28. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 103 8-K or 6-K reports in NANOVIRICIDES, INC.’s recent EDGAR index, the 4 listed here run from 2026-05-21 to 2026-09-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1379006 is on the EDGAR company page; the latest 10-K there is dated 2026-09-28 and the oldest filing in the recent index dates from 2006-11-14. Insider trades for NANOVIRICIDES, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Neonode

For “Neonode”, the matching SEC registrant is Neonode Inc., which trades as NEON and files under Central Index Key 87050. EDGAR puts it in the “Electronic Components, NEC” industry code with DE as its state or country of incorporation; its earlier registered name was Neonode, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-12, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-18 by Neonode Inc. (CIK 87050) — source document:

About Us Neonode provides software solutions for machine perception that feature advanced machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. We base our machine perception solutions on our MultiSensing® technology platform. We market and sell our solutions to customers mainly in the automotive market. However, our solution can also be used in many other markets, and we plan to expand our solutions into new markets in the future. Neonode also provides advanced optical sensing solutions for touch, contactless touch, and gesture sensing using our zForce® technology platform. In 2010, we began licensing to Original Equipment Manufacturers (“OEMs”) and automotive Tier 1 suppliers who embed our technology into products they develop, manufacture, and sell.

Financial trend for Neonode Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $5.67 million (2022-12-31) to $3.11 million (2024-12-31), a change of -45.2%; net income (loss) went from -$4.88 million (2022-12-31) to $8.49 million (2025-12-31), a change of +273.9%; total assets went from $21.20 million (2022-12-31) to $26.89 million (2025-12-31), a change of +26.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 87050, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Neonode Inc. did not tag for that period.

Neonode Inc. has 1000 filings in its recent EDGAR index, including 26 annual reports and 81 quarterly reports; its newest filing is a 10-Q from 2026-08-12.

Current reports. Of the 224 8-K or 6-K reports in Neonode Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-13 to 2026-08-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 87050 is on the EDGAR company page; the latest 10-K there is dated 2026-03-18 and the oldest filing in the recent index dates from 1999-10-12. Insider trades for Neonode Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Netstreit corp. bullish and bearish analyst opinions

For “Netstreit corp. bullish and bearish analyst opinions”, the matching SEC registrant is NETSTREIT Corp., which trades as NTST and files under Central Index Key 1798100. EDGAR puts it in the “Real Estate Investment Trusts” industry code with MD as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-10-22, across 461 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-10 by NETSTREIT Corp. (CIK 1798100) — source document:

We are an internally managed real estate company that acquires, owns, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. We also invest in property developments and mortgage loans secured by real estate. As of December 31, 2025, we owned or had investments in 761 properties diversified by tenant, industry, and geography, comprising 129 different tenants across 28 retail sectors in 45 states. This includes three property developments where rent has not yet commenced. We focus on tenants in industries where we believe a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including grocers, convenience stores, discount stores, home improvement, quick-service restaurants, general retail, and auto parts, all of which we refer to as defensive retail industries.

Financial trend for NETSTREIT Corp. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $96.28 million (2022-12-31) to $195.01 million (2025-12-31), a change of +102.5%; net income (loss) went from $8.21 million (2022-12-31) to $6.94 million (2025-12-31), a change of -15.4%; total assets went from $1.61 billion (2022-12-31) to $2.61 billion (2025-12-31), a change of +62.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1798100, tags Assets, ProfitLoss, Revenues; 4 periods shown, dashes mark figures NETSTREIT Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on NETSTREIT Corp. (CIK 1798100) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-21, and the most recent 10-K annual report was filed 2026-02-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 79 8-K or 6-K reports in NETSTREIT Corp.’s recent EDGAR index, the 4 listed here run from 2026-09-14 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1798100 is on the EDGAR company page; the latest 10-K there is dated 2026-02-10 and the oldest filing in the recent index dates from 2020-01-06. Insider trades for NETSTREIT Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Neuraxis, inc. bullish and bearish analyst opinions

For “Neuraxis, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Neuraxis, INC, which trades as NRXS and files under Central Index Key 1933567. EDGAR puts it in the “Electromedical & Electrotherapeutic Apparatus” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-14, across 193 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-19 by Neuraxis, INC (CIK 1933567) — source document:

Neuraxis, Inc. (“we”, “us”, the “Company” or “Neuraxis”) is a first-to-market growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. With several indications in the market and additional clinical trials of Percutaneous Electrical Nerve Field Stimulation (PENFS) in multiple pediatric and adult conditions underway, we are focused on unmet GI healthcare needs in children and adults. We are dedicated to advancing science with our proprietary IB-Stim ® therapy, based on our PENFS technology, which was developed internally by the Company. We believe that superior science and evidence-based research are necessary for adoption by the medical and scientific community.

Financial trend for Neuraxis, INC from annual reports, periods 2023-09-30 to 2025-12-31: revenue went from $2.46 million (2023-12-31) to $3.57 million (2025-12-31), a change of +45.1%; net income (loss) went from -$14.63 million (2023-12-31) to -$7.80 million (2025-12-31), a change of +46.7%; total assets went from $1.24 million (2023-09-30) to $6.40 million (2025-12-31), a change of +418.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1933567, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Neuraxis, INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Neuraxis, INC (CIK 1933567) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-04-21, and the most recent 10-K annual report was filed 2026-03-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 36 8-K or 6-K reports in Neuraxis, INC’s recent EDGAR index, the 4 listed here run from 2026-06-12 to 2026-10-14, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1933567 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2022-09-27. Insider trades for Neuraxis, INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Newel auctions leadership ceo jake baer news

What this search refers to. Newel’s CEO and leadership news is a private-company matter; the company’s own site and New York State corporation records are the official sources, since no SEC filing covers management changes at a non-registrant. Official source: apps.dos.ny.gov.

No SEC filer could be matched to “Newel auctions leadership ceo jake baer news” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Newel auctions leadership ceo jake baer”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “newel” (search terms considered: newel, auctions, leadership, ceo, jake, baer).

Even the shorter phrase “Newel auctions ceo” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (newel, auctions, leadership, ceo, jake, baer) point to a business outside the SEC system or one known by another legal name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “newel” 1, “auctions” 11, “leadership” 30, “ceo” 33, “jake” 37, “baer” 58. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “newel”: NEWEL CORP (CIK 1911489); containing “auctions”: GREG MANNING AUCTIONS INC (CIK 895516), INSURANCE AUTO AUCTIONS CORP. (CIK 1336782), INSURANCE AUTO AUCTIONS INC /CA (CIK 880026); containing “leadership”: CLOSED LOOP LEADERSHIP FUND II, LP (CIK 2109446), CLOSED LOOP LEADERSHIP FUND, LP (CIK 1766831), CULTIVATE LEADERSHIP INSTITUTE (CIK 1878790); containing “ceo”: CAROUSEL CAPITAL CEO FUND IV, L.P. (CIK 1525318), CAROUSEL CAPITAL CEO FUND V, L.P. (CIK 1688623), CAROUSEL CAPITAL CEO FUND VI, L.P. (CIK 1831136); containing “jake”: DELHOMME JAKE (CIK 1587495), DUNGAN JAKE A (CIK 1302341), ERHARD JAKE F (CIK 1430678). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: for recent news on “newel”, use the company’s own press releases or its home-exchange announcements, since there is no SEC 8-K feed for a non-filer. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Nyxoah s.a. bullish and bearish analyst opinions

For “Nyxoah s.a. bullish and bearish analyst opinions”, the matching SEC registrant is Nyxoah SA, which trades as NYXH and files under Central Index Key 1857190. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with Belgium as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20, across 178 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-26 by Nyxoah SA (CIK 1857190) — source document:

We were incorporated on July 15, 2009 as a company with limited liability (naamloze vennootschap/ société anonyme) incorporated and operating under the laws of Belgium. We are registered with the legal entities register (Brabant Wallon) under enterprise number 0817.149.675. We were publicly listed on Euronext Brussels in September 2020 and we were publicly listed on The Nasdaq Global Market in July 2021. We have four wholly owned subsidiaries: Nyxoah Ltd, an Israeli limited company incorporated in January 2008 under the name M.L.G. Madaf G. Ltd and our subsidiary since October 2009, Nyxoah Pty Ltd, an Australian limited company incorporated in 2017, Nyxoah, Inc., a Delaware corporation incorporated in May 2020, and Nyxoah GmbH, a German limited liability company incorporated in May 2023 under the name Blitz F23-668 GmbH and our subsidiary since July 2023.

Financial trend for Nyxoah SA from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -31,225,000 EUR (2022-12-31) to -90,085,000 EUR (2025-12-31), a change of -188.5%; total assets went from 146,071,000 EUR (2022-12-31) to 118,471,000 EUR (2025-12-31), a change of -18.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1857190, tags Assets, ProfitLoss; 4 periods shown, dashes mark figures Nyxoah SA did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Nyxoah SA (CIK 1857190) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-03-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 110 8-K or 6-K reports in Nyxoah SA’s recent EDGAR index, the 4 listed here run from 2026-08-05 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1857190 is on the EDGAR company page; the latest 20-F there is dated 2026-03-26 and the oldest filing in the recent index dates from 2021-04-16. Insider trades for Nyxoah SA appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Octopus (apac) holdings limited bullish and bearish analyst opinions

“Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. The name “Octopus (apac) holdings limited” therefore points to a company organised in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), and its official disclosures are on that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk), not on EDGAR.

No SEC filer could be matched to “Octopus (apac) holdings limited bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Octopus apac holdings limited”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “octopus” (search terms considered: octopus, apac).

A broader EDGAR full-text search for the shorter phrase “Octopus holdings limited” finds 23 filing documents; among the top 23, the filers mentioning it most are MTR CORP LTD (CIK 0001159204) (8); BIRDBILL, INC. (CIK 0001647771) (7); SU Group Holdings Ltd (SUGP) (CIK 0001969863) (5). Those are documents that name the term, not proof that any of these filers is the business in the search.

EDGAR’s company index has 15 entities whose registered name contains the word “octopus”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “octopus” 15, “apac” 6. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “octopus” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Olenox industries inc bullish and bearish analyst opinions

For “Olenox industries inc bullish and bearish analyst opinions”, the matching SEC registrant is OLENOX INDUSTRIES INC., which trades as OLOX and files under Central Index Key 1023994. EDGAR puts it in the “Wholesale-Lumber & Other Construction Materials” industry code with DE as its state or country of incorporation; its earlier registered name was SAFE & GREEN HOLDINGS CORP.. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-21 (this view begins at filings dated on or before 2026-07-29), across 929 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-06-30 by OLENOX INDUSTRIES INC. (CIK 1023994) (passage 2, continuing from the earlier excerpt) — source document:

In 2025, Modules were supplied for residential projects, military storage use and power generation enclosures. They were manufactured using our proprietary technology, design and engineering expertise, which includes modifying code-engineered cargo shipping containers and purpose-built modules for use for safe and sustainable commercial, industrial and residential building. On February 2, 2025, we executed a sign and close agreement to merge Olenox Industries Inc. (“OLOX”) with New Asia Holdings, Inc. (“NAHD”), the parent company of Olenox Corp. and Machfu, Inc. In December 2025, OLOX acquired Giant Containers Inc. Olenox Corp. is an oil & gas and renewable energy company, Machfu is an “Internet of Things,” or “IoT,” technology company with proprietary technology in remote monitoring.

Financial trend for OLENOX INDUSTRIES INC. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $1.05 million (2025-09-30) to $2.12 million (2026-06-30), a change of +101.5%; net income (loss) went from -$5.32 million (2025-09-30) to -$3.24 million (2026-06-30), a change of +39.0%; total assets went from $54.11 million (2025-09-30) to $64.18 million (2026-06-30), a change of +18.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1023994, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures OLENOX INDUSTRIES INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on OLENOX INDUSTRIES INC. (CIK 1023994) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2023-11-14, and the most recent 10-K annual report was filed 2026-06-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 278 8-K or 6-K reports in OLENOX INDUSTRIES INC.’s recent EDGAR index, the 4 listed here run from 2026-06-22 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1023994 is on the EDGAR company page; the latest 10-K there is dated 2026-06-30 and the oldest filing in the recent index dates from 1997-02-11. One example from this record is the 8-K/A filed 2026-08-11 (document). Insider trades for OLENOX INDUSTRIES INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Omnicell, inc. bullish and bearish analyst opinions

For “Omnicell, inc. bullish and bearish analyst opinions”, the matching SEC registrant is OMNICELL, INC., which trades as OMCL and files under Central Index Key 926326. EDGAR puts it in the “Electronic Computers” industry code with DE as its state or country of incorporation; its earlier registered name was OMNICELL, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-18, across 1004 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by OMNICELL, INC. (CIK 926326) — source document:

Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem. Our comprehensive set of solutions provides the critical foundation for customers to realize the Autonomous Pharmacy, an industry-wide vision defined by pharmacy leaders for improving operational efficiencies and ultimately targeting zero-error medication management alongside 5 other outcomes laid out in the Autonomous Pharmacy framework.

Financial trend for OMNICELL, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $5.65 million (2022-12-31) to $2.05 million (2025-12-31), a change of -63.7%; total assets went from $2.21 billion (2022-12-31) to $1.97 billion (2025-12-31), a change of -10.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 926326, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures OMNICELL, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on OMNICELL, INC. (CIK 926326) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-30, and the most recent 10-K annual report was filed 2026-02-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 145 8-K or 6-K reports in OMNICELL, INC.’s recent EDGAR index, the 4 listed here run from 2026-04-28 to 2026-07-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 926326 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2014-06-18. Insider trades for OMNICELL, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Oportun financial corporation bullish and bearish analyst opinions

For “Oportun financial corporation bullish and bearish analyst opinions”, the matching SEC registrant is Oportun Financial Corp, which trades as OPRT and files under Central Index Key 1538716. EDGAR puts it in the “Finance Services” industry code with DE as its state or country of incorporation; its earlier registered name was Progreso Financiero Holdings, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-14, across 742 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by Oportun Financial Corp (CIK 1538716) — source document:

With intelligent borrowing, savings, and budgeting capabilities, Oportun empowers its members with the confidence to build a better financial future. We design our products to holistically address two of the most fundamental challenges to financial health and resilience - access to responsible and affordable credit, and adequate savings. Financial Health in America According to a January 2026 survey by Bankrate, more than half of all Americans do not have enough savings to cover an unplanned expense of $1,000. When presented with an unexpected expense they cannot postpone, like a car that won’t start when one needs to get to work, or a required medical procedure, most people lack adequate savings and will typically require access to credit in order to cover their immediate need.

Financial trend for Oportun Financial Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $952.54 million (2022-12-31) to $956.68 million (2025-12-31), a change of +0.4%; net income (loss) went from -$77.74 million (2022-12-31) to $25.25 million (2025-12-31), a change of +132.5%; total assets went from $3.61 billion (2022-12-31) to $3.26 billion (2025-12-31), a change of -9.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1538716, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Oportun Financial Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Oportun Financial Corp (CIK 1538716) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-05, and the most recent 10-K annual report was filed 2026-02-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

For reported results, Oportun Financial Corp’s (CIK 1538716) latest 10-Q is dated 2026-08-06 and its latest annual report (10-K) 2026-02-27. Earnings releases appear as 8-K Item 2.02 filings; 34 are in the recent index, the newest on 2026-08-05.

Current reports. Of the 104 8-K or 6-K reports in Oportun Financial Corp’s recent EDGAR index, the 4 listed here run from 2026-08-05 to 2026-09-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1538716 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2012-01-09. Insider trades for Oportun Financial Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Osprey acquisition corp. iii forecast and analysis

For “Osprey acquisition corp. iii forecast and analysis”, the matching SEC registrant is Osprey Acquisition Corp. III, which trades as OSPR, OSPRU, OSPRW and files under Central Index Key 2113481. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-08-18, across 24 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Osprey Acquisition Corp. III (CIK 2113481) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Osprey Acquisition Corp. III — registration statements, prospectuses and merger proxies — are filed on EDGAR; 2 such filings (424B4, S-1) appear in its recent index, the newest dated 2026-07-02.

Current reports. Of the 3 8-K or 6-K reports in Osprey Acquisition Corp. III’s recent EDGAR index, the 3 listed here run from 2026-07-07 to 2026-08-18, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 24 recent EDGAR filings, Osprey Acquisition Corp. III most often filed 3 (11), 8-K (3), SCHEDULE 13G (2), 10-Q (1). A selection from 2026-07-02 to 2026-08-12:

The full record for CIK 2113481 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-03-06. Insider trades for Osprey Acquisition Corp. III appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ostin technology group co., ltd. bullish and bearish analyst opinions

For “Ostin technology group co., ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Ostin Technology Group Co., Ltd., which trades as OST and files under Central Index Key 1803407. EDGAR puts it in the “Electronic Components, NEC” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-06-18, across 134 filings on record. This is reference material, not trading advice.

Financial trend for Ostin Technology Group Co., Ltd. from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $105.42 million (2022-09-30) to $39.68 million (2025-09-30), a change of -62.4%; net income (loss) was tagged only for 2022-09-30 at $112,227; total assets went from $57.23 million (2022-09-30) to $53.25 million (2025-09-30), a change of -7.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1803407, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Ostin Technology Group Co., Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Ostin Technology Group Co., Ltd. (CIK 1803407) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-01-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 40 8-K or 6-K reports in Ostin Technology Group Co., Ltd.’s recent EDGAR index, the 4 listed here run from 2025-11-13 to 2026-06-18, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 134 recent EDGAR filings, Ostin Technology Group Co., Ltd. most often filed 6-K (40), CORRESP (16), UPLOAD (14), F-1/A (12). A selection from 2025-08-14 to 2026-04-02:

The full record for CIK 1803407 is on the EDGAR company page; the latest 20-F there is dated 2026-01-26 and the oldest filing in the recent index dates from 2020-09-28. Insider trades for Ostin Technology Group Co., Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pagaya technologies pgy latest news october 2026

For “Pagaya technologies pgy latest news october 2026”, the matching SEC registrant is Pagaya Technologies Ltd., which trades as PGY, PGYWW and files under Central Index Key 1883085. EDGAR puts it in the “Finance Services” industry code with Israel as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-20, across 481 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-02 by Pagaya Technologies Ltd. (CIK 1883085) — source document:

Pagaya Technologies Ltd. was incorporated on March 20, 2016 and is organized under the laws of the State of Israel. We are registered with the Israeli Registrar of Companies, registration number 51-542127-9. In February 2024, Pagaya relocated its corporate headquarters to its current New York City office. The U.S. is where we conduct our business, generate the majority of our revenue, and where all of our Partners and SFR Partners are domiciled. The mailing address of our principal executive office is 335 Madison Ave, New York, NY 10017, telephone number +1 646-710-7714. Our office in Tel-Aviv, Israel is Azrieli Sarona Bldg, 54th Floor, 121 Derech Menachem Begin, Tel-Aviv, 6701203, Israel, telephone number +972 (3) 715 0920.

Financial trend for Pagaya Technologies Ltd. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $748.93 million (2022-12-31) to $1.30 billion (2025-12-31), a change of +73.8%; net income (loss) went from -$302.32 million (2022-12-31) to $81.39 million (2025-12-31), a change of +126.9%; total assets went from $1.05 billion (2022-12-31) to $1.55 billion (2025-12-31), a change of +47.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1883085, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Pagaya Technologies Ltd. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Pagaya Technologies Ltd. (CIK 1883085) filed 66 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-05, and its overall latest filing is a 4 dated 2026-10-20. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 66 8-K or 6-K reports in Pagaya Technologies Ltd.’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-10-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1883085 is on the EDGAR company page; the latest 10-K/A there is dated 2026-06-01 and the oldest filing in the recent index dates from 2021-09-15. Insider trades for Pagaya Technologies Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pangaea connectivity technology limited bullish and bearish analyst opinions

The legal-form ending in “Pangaea connectivity technology limited” is the clue: “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. A company of that kind reports in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), so the place to read its annual report and announcements is that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) — www.hkexnews.hk.

No SEC filer could be matched to “Pangaea connectivity technology limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pangaea connectivity technology limited” appears in 19 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “pangaea” (search terms considered: pangaea, connectivity, technology).

A broader EDGAR full-text search for the shorter phrase “Pangaea connectivity technology” finds 19 filing documents; among the top 19, the filers mentioning it most are Happy City Holdings Ltd (HCHL) (CIK 0002046656) (9); Happy City Holdings Ltd (CIK 0002046656) (3); CALM Chain International Ltd (CIK 0002083945) (3). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 19 most relevant full-text hits returned for “Pangaea connectivity technology limited”, filings range from 2024-12-03 to 2026-08-26. The filers whose documents mention it most often are Happy City Holdings Ltd (HCHL) (CIK 0002046656) (9 hits); Happy City Holdings Ltd (CIK 0002046656) (3 hits); CALM Chain International Ltd (CIK 0002083945) (3 hits); CALM Chain International Ltd (CCIL) (CIK 0002083945) (3 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 32 entities whose registered name contains the word “pangaea”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “pangaea” 32, “connectivity” 17, “technology” 485. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “pangaea” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Perimeter solutions prm news october 2026

For “Perimeter solutions prm news october 2026”, the matching SEC registrant is Perimeter Solutions, Inc., which trades as PRM and files under Central Index Key 1880319. EDGAR puts it in the “Chemicals & Allied Products” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was Perimeter Solutions, SA. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-08-14 (this view begins at filings dated on or before 2026-05-22), across 337 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by Perimeter Solutions, Inc. (CIK 1880319) (passage 2, continuing from the earlier excerpt) — source document:

These Operational Value Drivers are overseen by general managers that operate in our decentralized operating structure. These managers have full operational autonomy paired with accountability to deliver results for customers and stockholders, with strong alignment between compensation and results. We believe our Operational Value Drivers maximize our free cash flow. We then seek to maximize long-term per share equity value through a clear focus on the allocation of our capital as well as the management of our capital structure. We expect the combination of free cash flow and incremental borrowing capacity generates substantial capital available to allocate. We believe our capital allocation strategy, which prioritizes first high-return organic reinvestment opportunities, followed by opportunistic share repurchases, and finally the acquisition of new businesses, is a critical factor in achieving Perimeter’s dual purposes: serving our customers well while delivering private-equity-like stockholder returns.

Financial trend for Perimeter Solutions, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from -$90.66 million (2025-09-30) to -$181.63 million (2026-06-30), a change of -100.3%; total assets went from $2.65 billion (2025-09-30) to $3.24 billion (2026-06-30), a change of +22.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1880319, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Perimeter Solutions, Inc. did not tag for that period.

Current reports. Of the 45 8-K or 6-K reports in Perimeter Solutions, Inc.’s recent EDGAR index, the 4 listed here run from 2025-12-15 to 2026-01-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1880319 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2021-09-01. One example from this record is the 4/A filed 2026-07-13 (document). Insider trades for Perimeter Solutions, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ping an biomedical co., ltd. bullish and bearish analyst opinions

For “Ping an biomedical co., ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Ping An Biomedical Co., Ltd., which trades as PASW and files under Central Index Key 1897532. EDGAR puts it in the “Apparel & Other Finishd Prods of Fabrics & Similar Matl” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Majestic Ideal Holdings Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a F-3 filed 2026-10-23, across 107 filings on record. This is reference material, not trading advice.

Financial trend for Ping An Biomedical Co., Ltd. from annual reports, periods 2023-09-30 to 2025-09-30: revenue went from 82,563,751 CNY (2023-09-30) to 34,147,936 CNY (2025-09-30), a change of -58.6%; net income (loss) went from -993,937 CNY (2023-09-30) to -12,829,206 CNY (2025-09-30), a change of -1190.7%; total assets went from 56,849,755 CNY (2024-09-30) to 68,414,527 CNY (2025-09-30), a change of +20.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1897532, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Ping An Biomedical Co., Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Ping An Biomedical Co., Ltd. (CIK 1897532) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-01-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 19 8-K or 6-K reports in Ping An Biomedical Co., Ltd.’s recent EDGAR index, the 4 listed here run from 2026-08-07 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 107 recent EDGAR filings, Ping An Biomedical Co., Ltd. most often filed 6-K (19), UPLOAD (17), F-1/A (14), CORRESP (13). A selection from 2026-04-01 to 2026-10-23:

The full record for CIK 1897532 is on the EDGAR company page; the latest 20-F there is dated 2026-01-30 and the oldest filing in the recent index dates from 2021-12-21. Insider trades for Ping An Biomedical Co., Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Polaris media asa bullish and bearish analyst opinions

The legal-form ending in “Polaris media asa” is the clue: “ASA” is the Norwegian public limited company form (allmennaksjeselskap). A company of that kind reports in Norway, so the place to read its annual report and announcements is the Oslo Børs NewsWeb disclosure service — newsweb.oslobors.no.

No SEC filer could be matched to “Polaris media asa bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Polaris media asa” appears in 297+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “polaris” (search terms considered: polaris, media).

The wording suggests a business based in Norway. Companies there file with Oslo Børs and Finanstilsynet rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “polaris” is therefore the Norway regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “Polaris media asa”, filings range from 2010-03-26 to 2026-08-28. The filers whose documents mention it most often are SPDR INDEX SHARES FUNDS (CIK 0001168164) (91 hits); STATOIL ASA (EQNR, STOHF) (CIK 0001140625) (8 hits); BRIGHAM EXPLORATION CO (CIK 0001034755) (2 hits); EQUINOR ASA (EQNR, STOHF) (CIK 0001140625) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 185 entities whose registered name contains the word “polaris”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “polaris” 185, “media” 480. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “polaris” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Progyny reddit

For “Progyny reddit”, the matching SEC registrant is Progyny, Inc., which trades as PGNY and files under Central Index Key 1551306. EDGAR puts it in the “Services-Misc Health & Allied Services, NEC” industry code with DE as its state or country of incorporation; its earlier registered name was Auxogyn, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-16, across 929 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by Progyny, Inc. (CIK 1551306) — source document:

Progyny is a global leader in women’s health and family building solutions. We envision a world where everyone can realize their dreams of family and ideal health. Our mission is to empower healthier, supported journeys through transformative fertility, family building and women’s health benefits. Through our differentiated approach to benefits plan design, member education and support and active network management, our clients’ employees are able to pursue the most effective treatment across life’s milestones from the best providers and specialists and achieve optimal outcomes. We launched our fertility benefits solution in 2016 with five employer clients and have since expanded our platform to include solutions in pregnancy and postpartum, menopause and midlife, benefit and leave navigation and parent and child wellbeing in order to address the continuum of women’s health.

Financial trend for Progyny, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $786.91 million (2022-12-31) to $1.29 billion (2025-12-31), a change of +63.8%; net income (loss) went from $30.36 million (2022-12-31) to $58.52 million (2025-12-31), a change of +92.8%; total assets went from $542.99 million (2022-12-31) to $742.43 million (2025-12-31), a change of +36.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1551306, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Progyny, Inc. did not tag for that period.

Reddit threads about Progyny, Inc., CIK 1551306, are user opinions, not disclosures. Claims made there can be checked against the filer record: 929 filings sit in its recent EDGAR index, the newest a 4 dated 2026-10-16, and 651 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 58 8-K or 6-K reports in Progyny, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1551306 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2012-06-04. Insider trades for Progyny, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Prokidney corp. bullish and bearish analyst opinions

For “Prokidney corp. bullish and bearish analyst opinions”, the matching SEC registrant is PROKIDNEY CORP., which trades as PROK and files under Central Index Key 1850270. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Social Capital Suvretta Holdings Corp. III. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-20, across 397 filings on record. This is reference material, not trading advice.

Financial trend for PROKIDNEY CORP. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2022-12-31) to $893,000 (2025-12-31); net income (loss) went from -$35.47 million (2023-12-31) to -$68.99 million (2025-12-31), a change of -94.5%; total assets went from $518.00 million (2022-12-31) to $335.57 million (2025-12-31), a change of -35.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1850270, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerIncludingAssessedTax; 4 periods shown, dashes mark figures PROKIDNEY CORP. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on PROKIDNEY CORP. (CIK 1850270) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-10, and the most recent 10-K annual report was filed 2026-03-18. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 62 8-K or 6-K reports in PROKIDNEY CORP.’s recent EDGAR index, the 4 listed here run from 2026-03-18 to 2026-08-10, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 397 recent EDGAR filings, PROKIDNEY CORP. most often filed 4 (124), 8-K (62), 3 (26), DEFA14A (22). A selection from 2026-08-10 to 2026-08-20:

The full record for CIK 1850270 is on the EDGAR company page; the latest 10-K there is dated 2026-03-18 and the oldest filing in the recent index dates from 2021-04-21. Insider trades for PROKIDNEY CORP. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Propanc biopharma, inc. bullish and bearish analyst opinions

For “Propanc biopharma, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Propanc Biopharma, Inc., which trades as PPCB and files under Central Index Key 1517681. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Propanc Health Group Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEF 14C filed 2026-10-21, across 437 filings on record. This is reference material, not trading advice.

Financial trend for Propanc Biopharma, Inc. from annual reports, periods 2023-06-30 to 2026-06-30: net income (loss) went from -$2.66 million (2023-06-30) to -$18.86 million (2026-06-30), a change of -609.0%; total assets went from $60,328 (2023-06-30) to $12.78 million (2026-06-30), a change of +21084.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1517681, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Propanc Biopharma, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Propanc Biopharma, Inc. (CIK 1517681) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-09-25. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 129 8-K or 6-K reports in Propanc Biopharma, Inc.’s recent EDGAR index, the 4 listed here run from 2025-11-10 to 2026-07-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 437 recent EDGAR filings, Propanc Biopharma, Inc. most often filed 8-K (129), 10-Q (44), CORRESP (37), 424B3 (25). A selection from 2026-08-21 to 2026-10-21:

The full record for CIK 1517681 is on the EDGAR company page; the latest 10-K there is dated 2026-09-25 and the oldest filing in the recent index dates from 2011-06-23. Insider trades for Propanc Biopharma, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Protalix biotherapeutics, inc. bullish and bearish analyst opinions

For “Protalix biotherapeutics, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Protalix BioTherapeutics, Inc., which trades as PLX and files under Central Index Key 1006281. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was ORTHODONTIX INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G filed 2026-10-15, across 972 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-18 by Protalix BioTherapeutics, Inc. (CIK 1006281) — source document:

We are a commercial stage biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with significant unmet needs. We are the first and only company to gain FDA approval of a protein produced through plant cell-based expression in suspension. ProCellEx®, our unique, proprietary plant cell-based protein expression system represents a new method for developing recombinant proteins in an industrial-scale manner. Our corporate strategy includes development of treatments for rare and orphan diseases. To execute on our strategy, we are turning our focus to new, early-stage product candidates that treat indications for which there are high unmet needs in terms of efficacy and safety, including renal diseases.

Financial trend for Protalix BioTherapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $47.64 million (2022-12-31) to $52.74 million (2025-12-31), a change of +10.7%; net income (loss) went from -$14.93 million (2022-12-31) to -$6.60 million (2025-12-31), a change of +55.8%; total assets went from $55.79 million (2022-12-31) to $82.35 million (2025-12-31), a change of +47.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1006281, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Protalix BioTherapeutics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Protalix BioTherapeutics, Inc. (CIK 1006281) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-12, and the most recent 10-K annual report was filed 2026-03-18. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 334 8-K or 6-K reports in Protalix BioTherapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-13 to 2026-08-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1006281 is on the EDGAR company page; the latest 10-K there is dated 2026-03-18 and the oldest filing in the recent index dates from 1996-08-13. Insider trades for Protalix BioTherapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Prothena corporation plc bullish and bearish analyst opinions

For “Prothena corporation plc bullish and bearish analyst opinions”, the matching SEC registrant is PROTHENA CORP PUBLIC LTD CO, which trades as PRTA and files under Central Index Key 1559053. EDGAR puts it in the “Pharmaceutical Preparations” industry code with Ireland as its state or country of incorporation; its earlier registered name was Prothena Corp plc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-15, across 1001 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by PROTHENA CORP PUBLIC LTD CO (CIK 1559053) — source document:

Prothena Corporation plc (“Prothena” or the “Company”) is a late-stage clinical biotechnology company with expertise in protein dysregulation with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Fueled by its deep scientific expertise built over decades of research, the Company is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. The Company’s pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including Parkinson’s disease, ATTR amyloidosis with cardiomyopathy, Alzheimer’s disease, Amyotrophic lateral sclerosis (ALS) and a number of other neurodegenerative diseases.

Financial trend for PROTHENA CORP PUBLIC LTD CO from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$116.95 million (2022-12-31) to -$244.09 million (2025-12-31), a change of -108.7%; total assets went from $758.03 million (2022-12-31) to $326.80 million (2025-12-31), a change of -56.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1559053, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures PROTHENA CORP PUBLIC LTD CO did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on PROTHENA CORP PUBLIC LTD CO (CIK 1559053) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-02-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 154 8-K or 6-K reports in PROTHENA CORP PUBLIC LTD CO’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-10-02, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1559053 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2013-01-31. Insider trades for PROTHENA CORP PUBLIC LTD CO appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pt iim

What this search refers to. “PT IIM” is an Indonesian limited-company abbreviation; Indonesian companies are registered with the Ministry of Law (AHU), and only those ending in “Tbk” are listed on IDX. Official source: ahu.go.id.

No SEC filer could be matched to “Pt iim” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Pt iim”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “iim” (search terms considered: iim).

EDGAR’s company index has 3 entities whose registered name contains the word “iim”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “iim” 3. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “iim”: FBV IIM, A SERIES OF FIREBOLT VENTURES FUND II, LP (CIK 1807655), IIM GLOBAL CORP (CIK 1534154), IIM HARRISON PARTNERS, LLC (CIK 1965494). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “iim” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt pp properti tbk bullish and bearish analyst opinions

Read from its name, “Pt pp properti tbk” is a Indonesia entity — “PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. Its accounts and exchange notices are published through the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Pt pp properti tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt pp properti tbk” appears in 110+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “properti” (search terms considered: properti).

A broader EDGAR full-text search for the shorter phrase “Pt pp properti” finds 110+ filing documents; among the top 100, the filers mentioning it most are COLLEGE RETIREMENT EQUITIES FUND (CIK 0000777535) (29); DBX ETF TRUST (CIK 0001503123) (21); FIDELITY SALEM STREET TRUST (CIK 0000035315) (16). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “properti” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “Pt pp properti tbk”, filings range from 2017-03-31 to 2024-02-02. The filers whose documents mention it most often are COLLEGE RETIREMENT EQUITIES FUND (CIK 0000777535) (29 hits); DBX ETF TRUST (CIK 0001503123) (21 hits); FIDELITY SALEM STREET TRUST (CIK 0000035315) (16 hits); VANGUARD INTERNATIONAL EQUITY INDEX FUNDS (CIK 0000857489) (5 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 0 entities whose registered name contains the word “properti”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “properti” 0. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “properti” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pw medtech group limited bullish and bearish analyst opinions

For “Pw medtech group limited bullish and bearish analyst opinions”, the matching SEC registrant is PW Medtech Group Ltd, which trades as none listed and files under Central Index Key 1726917. EDGAR puts it in the “no SIC description” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SC 13D/A filed 2021-01-08, across 13 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on PW Medtech Group Ltd (CIK 1726917) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

What kind of filer this is matters for “Pw medtech group limited bullish and bearish analyst opinions”: PW Medtech Group Ltd’s EDGAR record from 2018-01-10 to 2021-01-08 consists only of SC 13D/A filings; Schedule 13D ownership reports as an active large holder in another company. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Other filings. Across its 13 recent EDGAR filings, PW Medtech Group Ltd most often filed SC 13D/A (12), SC 13D (1). A selection from 2020-09-17 to 2021-01-08:

The full record for CIK 1726917 is on the EDGAR company page and the oldest filing in the recent index dates from 2018-01-10. Insider trades for PW Medtech Group Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Qumulusai, inc. common stock bullish and bearish analyst opinions

For “Qumulusai, inc. common stock bullish and bearish analyst opinions”, the matching SEC registrant is QumulusAI, Inc., which trades as QMLS and files under Central Index Key 2084026. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with GA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 3/A filed 2026-10-20, across 66 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on QumulusAI, Inc. (CIK 2084026) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-25. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 5 8-K or 6-K reports in QumulusAI, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-16 to 2026-09-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 66 recent EDGAR filings, QumulusAI, Inc. most often filed 4 (21), 3 (15), S-1/A (7), 8-K (5). A selection from 2026-10-05 to 2026-10-20:

The full record for CIK 2084026 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-09-03. Insider trades for QumulusAI, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Radware ip device cve 2026

For “Radware ip device cve 2026”, the matching SEC registrant is RADWARE LTD, which trades as RDWR and files under Central Index Key 1094366. EDGAR puts it in the “Services-Business Services, NEC” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-07, across 570 filings on record. This is reference material, not trading advice.

The Offer and Listing 109 A. Offer and Listing Details 109 B. Plan of Distribution 109 C. Markets 109 D. Selling Shareholders 109 E. Dilution 109 F. Expenses of the Issue 109 ITEM 10. Additional Information 110 A. Share Capital 110 B. Memorandum and Articles of Association 110 C. Material Contracts 110 D. Exchange Controls 110 E. Taxation 110 F. Dividends and Paying Agents 122 G. Statement by Experts 122 H. Documents on Display 122 I. Subsidiary Information 122 J. Annual Report to Security Holders 122 ITEM 11. Quantitative and Qualitative Disclosures about Market Risk 123 ITEM 12. Description of Securities other than Equity Securities 125 PART II 126 ITEM 13.

Adding a year to a CVE search narrows it to identifiers in the CVE-2026 range or advisories published this year, but NVD dates a record by when it was published, not when the flaw was introduced. For Radware appliances such as DefensePro or Alteon, the practical check is the release notes for the firmware actually deployed: an older identifier can still apply to a box that has not been patched, so filtering only by 2026 can hide open exposure.